145 related articles for article (PubMed ID: 29511313)
21. Forkhead box C1 promotes colorectal cancer metastasis through transactivating ITGA7 and FGFR4 expression.
Liu J; Zhang Z; Li X; Chen J; Wang G; Tian Z; Qian M; Chen Z; Guo H; Tang G; Huang W; Tian D; Wang D; Nie Y; Fan D; Wu K; Xia L
Oncogene; 2018 Oct; 37(41):5477-5491. PubMed ID: 29884889
[TBL] [Abstract][Full Text] [Related]
22. FOXC1 overexpression is a marker of poor response to anthracycline-based adjuvant chemotherapy in sporadic triple-negative breast cancer.
Xu YL; Yao R; Li J; Zhou YD; Mao F; Pan B; Sun Q
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1205-1213. PubMed ID: 28493031
[TBL] [Abstract][Full Text] [Related]
23. p38-regulated FOXC1 stability is required for colorectal cancer metastasis.
Zhang Y; Liao Y; Chen C; Sun W; Sun X; Liu Y; Xu E; Lai M; Zhang H
J Pathol; 2020 Feb; 250(2):217-230. PubMed ID: 31650548
[TBL] [Abstract][Full Text] [Related]
24. Exploring novel targets of basal-like breast carcinoma by comparative gene profiling and mechanism analysis.
Wu YM; Hu W; Wang Y; Wang N; Gao L; Chen ZZ; Zheng WQ
Breast Cancer Res Treat; 2013 Aug; 141(1):23-32. PubMed ID: 23933801
[TBL] [Abstract][Full Text] [Related]
25. ATF3-Induced Mammary Tumors Exhibit Molecular Features of Human Basal-Like Breast Cancer.
Yan L; Gaddis S; Coletta LD; Repass J; Powell KL; Simper MS; Chen Y; Byrom M; Zhong Y; Lin K; Liu B; Lu Y; Shen J; MacLeod MC
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652981
[TBL] [Abstract][Full Text] [Related]
26. The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expression.
Shepherd JH; Uray IP; Mazumdar A; Tsimelzon A; Savage M; Hilsenbeck SG; Brown PH
Oncotarget; 2016 Mar; 7(11):13106-21. PubMed ID: 26894864
[TBL] [Abstract][Full Text] [Related]
27. FOXC1-induced Gli2 activation: A non-canonical pathway contributing to stemness and anti-Hedgehog resistance in basal-like breast cancer.
Han B; Qu Y; Yu-Rice Y; Johnson J; Cui X
Mol Cell Oncol; 2016 May; 3(3):e1131668. PubMed ID: 27314088
[TBL] [Abstract][Full Text] [Related]
28. Tumor Hypoxia Regulates Forkhead Box C1 to Promote Lung Cancer Progression.
Lin YJ; Shyu WC; Chang CW; Wang CC; Wu CP; Lee HT; Chen LJ; Hsieh CH
Theranostics; 2017; 7(5):1177-1191. PubMed ID: 28435457
[TBL] [Abstract][Full Text] [Related]
29. Correlation of Forkhead Box c2 with subtypes and invasive ability of invasive breast cancer.
Dai J; Wang JY; Yang LL; Xiao Y; Qu ZL; Qin SH; Ruan QR
J Huazhong Univ Sci Technolog Med Sci; 2014 Dec; 34(6):896-901. PubMed ID: 25480587
[TBL] [Abstract][Full Text] [Related]
30. FOXC1-induced non-canonical WNT5A-MMP7 signaling regulates invasiveness in triple-negative breast cancer.
Han B; Zhou B; Qu Y; Gao B; Xu Y; Chung S; Tanaka H; Yang W; Giuliano AE; Cui X
Oncogene; 2018 Mar; 37(10):1399-1408. PubMed ID: 29249801
[TBL] [Abstract][Full Text] [Related]
31. FOXC1, the new player in the cancer sandbox.
Elian FA; Yan E; Walter MA
Oncotarget; 2018 Jan; 9(8):8165-8178. PubMed ID: 29487724
[TBL] [Abstract][Full Text] [Related]
32. BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers.
Tkocz D; Crawford NT; Buckley NE; Berry FB; Kennedy RD; Gorski JJ; Harkin DP; Mullan PB
Oncogene; 2012 Aug; 31(32):3667-78. PubMed ID: 22120723
[TBL] [Abstract][Full Text] [Related]
33. Single-gene diagnostic assay for rapid subclassification of basal like breast cancer with mRNA targeted antisense oligonucleotide capped molecular probe.
Moitra P; Alafeef M; Dighe K; Pan D
Biosens Bioelectron; 2022 Jul; 207():114178. PubMed ID: 35316757
[TBL] [Abstract][Full Text] [Related]
34. Reciprocal transrepression between FOXF2 and FOXQ1 controls basal-like breast cancer aggressiveness.
Kang LJ; Yu ZH; Cai J; He R; Lu JT; Hou C; Wang QS; Li XQ; Zhang R; Feng YM
FASEB J; 2019 May; 33(5):6564-6573. PubMed ID: 30807702
[TBL] [Abstract][Full Text] [Related]
35. Cancer Cell-Derived Granulocyte-Macrophage Colony-Stimulating Factor Is Dispensable for the Progression of 4T1 Murine Breast Cancer.
Yoshimura T; Nakamura K; Li C; Fujisawa M; Shiina T; Imamura M; Li T; Mukaida N; Matsukawa A
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31888216
[TBL] [Abstract][Full Text] [Related]
36. The long noncoding RNA FOXCUT promotes proliferation and migration by targeting FOXC1 in nasopharyngeal carcinoma.
Xu YZ; Chen FF; Zhang Y; Zhao QF; Guan XL; Wang HY; Li A; Lv X; Song SS; Zhou Y; Li XJ
Tumour Biol; 2017 Jun; 39(6):1010428317706054. PubMed ID: 28635400
[TBL] [Abstract][Full Text] [Related]
37. Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals Effects of the Epithelial Microenvironment on Tumor Progression and Metastasis.
Atiya HI; Dvorkin-Gheva A; Hassell J; Patel S; Parker RL; Hartstone-Rose A; Hodge J; Fan D; Ramsdell AF
Anticancer Res; 2019 May; 39(5):2277-2287. PubMed ID: 31092419
[TBL] [Abstract][Full Text] [Related]
38. Research progress on the regulatory mechanisms of FOXC1 expression in cancers and its role in drug resistance.
Yang Y; Li W; Yang H; Zhang Y; Zhang S; Xu F; Hao Y; Cao W; Du G; Wang J
Gene; 2024 Mar; 897():148079. PubMed ID: 38101711
[TBL] [Abstract][Full Text] [Related]
39. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
[TBL] [Abstract][Full Text] [Related]
40. FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer.
Cai J; Tian AX; Wang QS; Kong PZ; Du X; Li XQ; Feng YM
Cancer Lett; 2015 Oct; 367(2):129-37. PubMed ID: 26210254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
